Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents.

ABSTRACT:

Background

Hepatitis C Virus (HCV) infections are blood-borne, generally chronic and are associated with increased morbidity and mortality. The aim of this study is to describe the results of therapies with direct-acting antiviral agents (DAAs) in healthcare personnel.

Methods

Secondary data analysis using data from the Statutory Accident Insurance of the Health and Welfare Service. The study surveyed DAA therapies administered to insured parties (healthcare personnel with an HCV infection recognised as an occupational disease) in Germany between 01/01/2014 and 30/11/2016. The end points were results of monitorings carried out twelve weeks after the end of treatment (SVR12), side effects and the results of the assessment of reduced work ability after treatment. Multivariate

SUBMITTER: Westermann C 

PROVIDER: S-EPMC5970510 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature